bibliographic entry 6949487 [be/6949487]
https://w3id.org/oc/corpus/be/6949487

is a

• bibliographic reference

content

• Nauck MA, Ellis GC, Fleck PR, Wilson CA, Mekki Q. Alogliptin Study 008 Group. Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study. Int J Clin Pract 2009; 63:46-55. doi:10.1111/j.1742-1241.2008.01933.x. 19125992.

references

• https://w3id.org/oc/corpus/br/2310784